Fibromuscular dysplasia: an update for the headache clinician

Sarah C O'Connor1, Neil Poria2, Heather L Gornik3

  • 1Cleveland Clinic Lerner, College of Medicine, Case Western Reserve University, Cleveland, OH, USA.

Headache
|April 18, 2015
PubMed
Abstract

Insights

Fibromuscular dysplasia (FMD) is a rare vascular condition affecting medium-sized arteries, often leading to serious events. Headaches are a common symptom in FMD patients, but their cause requires further research.

Area of Science:

  • Vascular Medicine
  • Neurology
  • Radiology

Background:

  • Fibromuscular dysplasia (FMD) is an uncommon vascular disease affecting medium-sized arteries.
  • It commonly involves renal and extracranial carotid/vertebral arteries.
  • FMD is linked to significant vascular events like stroke and dissection.

Purpose of the Study:

  • To review current literature on FMD.
  • To focus on the association between FMD and headaches.
  • To highlight the need for further research into FMD-related headaches.

Main Methods:

  • Literature review of recent studies on FMD.
  • Analysis of epidemiological data, clinical manifestations, imaging, and treatment.
  • Specific focus on headache presentation in FMD patients.

Main Results:

  • FMD presents with diverse severity and symptoms related to affected vascular beds.
  • Headaches are a frequent and significant symptom in FMD patients.
  • The exact mechanism causing headaches in FMD remains unknown.

Conclusions:

  • Accurate diagnosis and management are crucial for FMD patients.
  • Optimal medical and interventional strategies are vital.
  • More research is needed on the epidemiology, pathophysiology, and treatment of headaches in FMD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
549
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
523
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.2K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
483
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K